Our website uses cookies to improve and personalise your experience and to display advertisements(if any). Our website may also include third-party cookies like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne diseases

A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne diseases

THE Research Brief is a short take about interesting academic work. The big idea A new laboratory-stage mRNA vaccine that teaches the immune system to recognize the saliva from tick bites could prevent these bugs from feeding on and transmitting tick-borne diseases to people, according to a recent study my colleagues and I conducted in the Fikrig Lab at the Yale School of Medicine. ANDALEEB SAJID, Staff Scientist, National Institutes of Health Some animals repeatedly exposed to tick bites are eventually able to develop resistance to tick feeding, where the ticks either detach soon after biting or cause skin redness…
Read More